The Tdap Vaccination in Pregnancy: Results of a Healthy Equity Audit on Coverage Trends and Their Determinants in the Reggio Emilia Province (Italy)
- PMID: 40266140
- PMCID: PMC11946158
- DOI: 10.3390/vaccines13030251
The Tdap Vaccination in Pregnancy: Results of a Healthy Equity Audit on Coverage Trends and Their Determinants in the Reggio Emilia Province (Italy)
Abstract
Background/Objectives: The Italian National Plan for Vaccine Prevention 2017-2019 recommended tetanus, diphtheria, and acellular pertussis vaccines (Tdap) for pregnant women, irrespectively of their immunization history. This study aims to describe the coverage rate trends for Tdap vaccination in pregnancy and evaluate the differences by socioeconomic status. Methods: This is a retrospective analysis within a health equity audit of the Local Health Authority of Reggio Emilia on vaccination in pregnancy from 2018 (a local vaccination campaign) to 2023. All women residents in our area who gave birth during that period were included and linked to the electronic Registry of Immunization Service. The vaccination coverage in pregnant women was analyzed over time and stratified by pregnant women's sociodemographic and obstetric characteristics. Results: The coverage of Tdap in pregnant women of the Province of Reggio Emilia increased from 15.9% in 2018 to 53.9% in 2023. The coverage was higher among Italians, women with higher educational levels (aPR 1.49 (CI95%1.41-1.57)), within 31-35 years of age (aPR 1.37 (CI95% 1.28-1.46)), occupied, nulliparous (aPR multiparous vs nulliparous: 0.76 (0.74; 0.78)), and followed in the private sector (aPR 1.07 (1.03-1.11)). Inequalities in coverage increased during the study period for women assisted in the private sector, while decreased or remained stable for women assisted in the context of public services. Conclusions: The vaccination promotion campaign in Reggio Emilia helped increase Tdap coverage in pregnancy from 16 to 53%. Nevertheless, the coverage rates of the most disadvantaged women are still several points lower than the average.
Keywords: Tdap; immunization; maternal vaccination; pregnancy; vaccine.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures



Similar articles
-
Trends and characteristics of Tdap vaccination during pregnancy in Ontario, Canada: a retrospective cohort study.CMAJ Open. 2022 Dec 6;10(4):E1017-E1026. doi: 10.9778/cmajo.20220058. Print 2022 Oct-Dec. CMAJ Open. 2022. PMID: 36735222 Free PMC article.
-
Insights and expectations for Tdap vaccination of pregnant women in Italy.J Matern Fetal Neonatal Med. 2021 Jul;34(13):2132-2139. doi: 10.1080/14767058.2019.1659240. Epub 2019 Sep 4. J Matern Fetal Neonatal Med. 2021. PMID: 31456459
-
Exploring Tdap and influenza vaccine uptake and its determinants in pregnancy: a cross-sectional study.Ann Ig. 2022 Jul-Aug;34(4):358-374. doi: 10.7416/ai.2022.2503. Epub 2022 Feb 24. Ann Ig. 2022. PMID: 35195239
-
Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2008 May 30;57(RR-4):1-51. MMWR Recomm Rep. 2008. PMID: 18509304 Review.
-
Factors associated with Tdap vaccination receipt during pregnancy: a cross-sectional study.Public Health. 2020 Feb;179:38-44. doi: 10.1016/j.puhe.2019.10.001. Epub 2019 Nov 11. Public Health. 2020. PMID: 31726399 Review.
References
-
- WHO. [(accessed on 19 May 2023)]. Available online: https://www.who.int/initiatives/maternal-and-neonatal-tetanus-eliminatio...
-
- Centers for Disease Control and Prevention (CDC) Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women–Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb. Mortal. Wkly. Rep. 2013;62:131–135. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous